BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19164248)

  • 1. Ultrafiltration and the buffer: one more interaction to consider?
    Holmes CJ
    Perit Dial Int; 2009; 29(1):20-2. PubMed ID: 19164248
    [No Abstract]   [Full Text] [Related]  

  • 2. Substituting citrate for lactate in peritoneal dialysis fluid improves ultrafiltration in rats.
    Cavallini N; Wieslander A; Braide M
    Perit Dial Int; 2009; 29(1):36-43. PubMed ID: 19164251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine is an osmotic agent suitable for peritoneal dialysis.
    Bonomini M; Pandolfi A; Di Liberato L; Di Silvestre S; Cnops Y; Di Tomo P; D'Arezzo M; Monaco MP; Giardinelli A; Di Pietro N; Devuyst O; Arduini A
    Kidney Int; 2011 Sep; 80(6):645-54. PubMed ID: 21525850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.
    Albrektsson A; Bazargani F; Wieslander A; Braide M
    ASAIO J; 2006; 52(3):276-81. PubMed ID: 16760716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
    Opatrná S; Opatrný K; Racek J; Sefrna F
    Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
    [No Abstract]   [Full Text] [Related]  

  • 7. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin and the peritoneal membrane.
    Margetts P
    Perit Dial Int; 2009; 29(1):16-9. PubMed ID: 19164247
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bicarbonate buffered dialysate on human peritoneal mesothelial cell intracellular calcium homeostasis.
    Bird SD; Walker RJ
    Nephrology (Carlton); 2003 Jun; 8(3):150-5. PubMed ID: 15012732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the variability in ultrafiltration obtained with icodextrin.
    Lambie M; Stompor T; Davies S
    Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactate-versus bicarbonate-based peritoneal dialysis solutions.
    Pedersen FB
    Perit Dial Int; 1995; 15(7 Suppl):S47-50; discussion S51. PubMed ID: 8555326
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on peritoneal dialysis solutions.
    McIntyre CW
    Kidney Int; 2007 Mar; 71(6):486-90. PubMed ID: 17299524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
    Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
    Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
    Gotloib L
    Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of new peritoneal dialysis solutions in children.
    Canepa A; Verrina E; Perfumo F
    Kidney Int Suppl; 2008 Apr; (108):S137-44. PubMed ID: 18379537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference in causes of early and late ultrafiltration failure in peritoneal dialysis.
    Smit W; Parikova A; Struijk DG; Krediet RT
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S41-5. PubMed ID: 16048254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
    Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
    Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying the effects of new peritoneal dialysis solutions on the peritoneum.
    Chan TM; Yung S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S87-93. PubMed ID: 17556337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.